Investors who lost money on Supernus Pharmaceuticals, Inc. should contact Levi & Korsinsky about an ongoing investigation - SUPN
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
7,978 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Acquired by Atria Investments Inc
Atria Investments Inc bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 7,978 shares of the specialty ...
Cantor Fitzgerald Sticks to Its Buy Rating for Sarepta Therapeutics (SRPT)
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...